Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Brickellia grandiflora
Mexican bitter herb for diabetes and digestive conditions.
Brickellia grandiflora, commonly known as Prodigiosa Mexicana, is a bitter herb traditionally used in Mexican folk medicine for diabetes and digestive disorders. Its primary active compounds include sesquiterpene lactones, flavonoids, and brickellin, which contribute to its anti-diabetic, cholagogue, and bitter digestive properties. Evidence is limited (Level C) but suggests potential benefits for glycemic control and bile flow.
The sesquiterpene lactones in Brickellia grandiflora are believed to stimulate bitter taste receptors (T2Rs) on the tongue and in the gut, leading to increased gastric acid secretion and bile release via cholecystokinin (CCK) pathways. Additionally, flavonoids such as brickellin may enhance insulin sensitivity and inhibit α-glucosidase enzymes, reducing postprandial hyperglycemia. The herb's hypoglycemic effect may also involve activation of AMPK and modulation of PPARγ, though human data are scarce.
Mexican bitter herb for diabetes and digestive conditions.
Brickellia grandiflora, commonly known as Prodigiosa Mexicana, is a bitter herb traditionally used in Mexican folk medicine for diabetes and digestive disorders. Its primary active compounds include sesquiterpene lactones, flavonoids, and brickellin, which contribute to its anti-diabetic, cholagogue, and bitter digestive properties. Evidence is limited (Level C) but suggests potential benefits for glycemic control and bile flow.
The sesquiterpene lactones in Brickellia grandiflora are believed to stimulate bitter taste receptors (T2Rs) on the tongue and in the gut, leading to increased gastric acid secretion and bile release via cholecystokinin (CCK) pathways. Additionally, flavonoids such as brickellin may enhance insulin sensitivity and inhibit α-glucosidase enzymes, reducing postprandial hyperglycemia. The herb's hypoglycemic effect may also involve activation of AMPK and modulation of PPARγ, though human data are scarce.